Replies to post #638623 on NorthWest Biotherapeutics Inc (NWBO)

[eagle8]

I agree with you flipper.

As soon as DCvax (+ possibly Poli ICLC), will be the new SOC for GBM and rGBM,
the CIs will no longer be anything but additions.
The greatest value is of course in destroying the cancer cells, so DCvax.
CIs, there are several of them.
And when single they also have ugly side effects, I once learned from you.
And then we haven't even talked about the tumor agnostic aspect.
I think Merck has little choice and will have to dig deep into its pockets.
Otherwise that $21 billion in turnover could end up with another company.
NWBO of course.

GLTU